Xeris Biopharma President, COO Kevin McCulloch sells 15,000 shares for $120,240

• Xeris Biopharma President, Chief Operating Officer Kevin McCulloch sold 15,000 common shares on Aug. 3, 2026 at USD 8.02.
• Directly held stake rose to 1,676,126 shares following the transaction.
• Form 4 also reported 25,000 shares held indirectly by his spouse.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001867096-26-000059), on August 04, 2026, and is solely responsible for the information contained therein.